HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model

Diabetologia

Volumn 46, Issue 1, 2003, Pages 115-123

  Nakabayashi, M ^b   Morishita, R ^a,b   Nakagami, H ^b   Kuba, K ^b   Matsumoto, K ^b   Nakamura, T ^b   Tano, Y ^b   Kaneda, Y ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Endothelial cell; HGF; Retinopathy; Vascular endothelial growth factor

Indexed keywords

ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; OKADAIC ACID; PHOSPHATASE; SCATTER FACTOR; TRANSCRIPTION FACTOR ETS 1; VANADATE SODIUM; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; BIOASSAY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RABBIT;

EID: 0037286698     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0954-y     Document Type: Article

References (36)

1. Cordeiro MF, Stanford MR, Phillips PM, Shilling JS (1997) Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy. Eye 11:531-536
2. Aiello LP, Avery RL, Arrigg PG et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487
3. Adamis AP, Miller JW, Bernal et al. (1994) Increased vascular endothelial growth factor levels in the vitreous fluid of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118: 445-450
4. Early Treatment Diabetic Retinopathy Study Research Group (1991) Early photocoagulation for diabetic retinopathy. ETDRS report no. 9. Ophthalmology 98: 766-785
5. Date K, Matsumoto K, Shimura H, Tanaka M, Nakamura T (1997) HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett 420: 1-6
6. Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T (1998) Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene 17: 3045-3054
7. Jain RK, Schlenger K, Hockel M, Yuan F (1997) Quantitative angiogenesis assays; Progress and problems. Nat Med 3: 1203-1208
8. Amano S, Roban R, Kuroki M, Tolentino M, Adamis AP (1998) Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 39: 18-22
9. Morishita R, Nakamura S, Nakamura Y et al. (1997) Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes. Diabetes 46: 138-142
10. Wernert N Gilles F, Fafeur V, et al. (1994) Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res 54: 5683-5688
11. Sato Y (1998) Transcription factor ETS-1 as a molecular target for angiogenesis inhibition. Hum Cell 11: 207-214
12. Valter MM, Hugel A, Huang HJ et al. (1999) Expression of the Ets1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 59: 5608-5614
13. Kroll J, Waltenberger J (1997) The vascular endothelial growth factor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 272: 32521-32527
14. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931-10934
15. O'Reilly MS, Boehm T, Shing Y et al. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328
16. O'Reilly MS et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285
17. O'Reilly MS, Holmgren L, Chen C, Folkman J (1994) Angiostatin induces and sustains dormancy of metastases by a Lewis lung carcinoma. Cell 79: 315-328
18. Dvorak HF, Brown LF, Detmer M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039
19. Klein R, Klein BEK (1985) Vision disorders in diabetes. In: Harris MI, Hamman RF (eds) Diabetes in America (NIH Publ. 85-1468). US Dept of Health and Human Services, Bethesda, MD, pp 1-2
20. Sa G, Murugesan G, Jaye M, Ivashchenko Y, Fox PL (1995) Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem 270: 2360-2366
21. Klemke RL, Cai S, Giannini AL, Gallagher PJ, Lanerolle P de, Cheresh DA (1997) Regulation of cell motility by mitogen-activated protein kinase. J Biol Chem 137: 481-492
22. Hughes PE, Renshaw MW, Pfaff Met al. (1997) Suppression of integrin activation: a novel function of a Ras/Rafinitiated MAP kinase pathway. Cell 88: 521-530
23. Gum R, Wang H, Lengyel E, Juarez J, Boyd D (1997) Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14: 1481-1493
24. Besser D, Presta M, Nagamine Y (1995) Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH3T3 fibroblasts. Cell Growth Differ 6: 1009-1017
25. Lengyel E, Stepp E, Gum R, Boyd D (1995) Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras. J Biol Chem 270: 23007-23012
26. Lengyel E, Wang H, Gum R, Simon C, Wang Y, Boyd D (1997) Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Oncogene 14: 2563-2573
27. Maru Y, Yamaguchi S, Takahashi T, Ueno H, Shibuya M (1998) Virally activated ras cooperates with integrins to tubulogenesis in sinusoidal endothelial cell lines. J Cell Phys 176: 223-234
28. Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA, Stehelin D (1989) Complementary patterns of expression of c-ets-1, c-myb and c-myc in the bloodforming systems of the chick embryo. Development 107: 265-274
29. Kola I, Brookes S, Green AR et al. (1993) The ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenic processes such as organ formation. Proc Natl Acad Sci USA 90: 7588-7592
30. c-ers-1, the two transcription factors encoded by the c-ets-1 locus, are differentially expressed during the development of chick embryo. Oncogene 8: 2511-2520
31. Wasylyk C, Gutman A, Nicholson R, Wasylik B (1991) c-ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 10: 1127-1134
32. Desbiens X, Queva C, Jaffredo T, Strehelin D, Vandenbunder B (1991) The relationship between cell proliferation and the transcription of the nuclear oncogenes c-myc, c-myb and c-ets-1 during feather morphogenesis in the chick embryo. Development 111: 699-713
33. Aoki M, Morishita R, Taniyama Y et al. (2000) Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther 7: 417-427
34. Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T (2000) HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res. 60: 6737-6743
35. Redlitz A, Daum G, Sage EH (1999) Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells. J Vasc Res 36: 28-34
36. Cao Y, Ji RW, Davidson D et al. (1996) Kringle domains of human angiostatin. J Biol Chem 271: 29461-29467